Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000424) titled 'A Study on the Clinical Efficacy and Relationship with Brain Function of Compound Cistanche Intellect Capsules in Regulating the "Nephroencephalic Axis" and "Hepatoencephalic Axis" for the Treatment of Mild to Moderate Alzheimer's Disease' on Feb. 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tongde Hospital of Zhejiang Province
Condition:
Alzheimer's Disease
Intervention:
Experimental Group:Compound Cistanche Intellecti-boosting Capsules 0.3g per capsule, 4 capsules each time, orally, 3 times daily
Recruitment Status: Not Recruiting
Phase: Others
Date of First Enrollme...